← Eichor
Condition: Protein Kinase Inhibitors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Protein Kinase Inhibitors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Long-term Extension Study of PCI-32765 (Ibrutinib)
Phase 3 · 175 location(s) · Janssen Research & Development, LLC · NCT01804686Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
Phase 1 · 1 location(s) · Guangzhou JOYO Pharma Co., Ltd · NCT06128148Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Li
Phase 3 · 78 location(s) · ArriVent BioPharma, Inc. · NCT07185997A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lympho
Phase 3 · 124 location(s) · BeOne Medicines · NCT06846671Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
NA · 1 location(s) · Northwell Health · NCT05643235DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Phase 2/Phase 3 · 17 location(s) · Cancer Research UK · NCT06988475Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Phase 1/Phase 2 · 13 location(s) · Celcuity Inc · NCT06190899A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 79 location(s) · Artios Pharma Ltd · NCT04657068A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
Phase 1 · 2 location(s) · Changshan ConjuChem BioPharmaceutical Research and Developme · NCT06717750A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Ch
Phase 3 · 197 location(s) · BeOne Medicines · NCT06973187DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Canc
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770037International Chronic Myeloid Leukemia Pediatric Study
Phase N/A · 20 location(s) · Poitiers University Hospital · NCT01281735DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusio
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770544A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymp
Phase 2 · 32 location(s) · Nurix Therapeutics, Inc. · NCT07221500DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05722886Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
Phase 2 · 1 location(s) · Peking University Cancer Hospital & Institute · NCT05512481Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO
NA · 1 location(s) · Fondazione Ricerca e Innovazione Cardiovascolare ETS · NCT06535568Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies U
Phase N/A · 1 location(s) · Mayo Clinic · NCT06151730
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.